Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - STOCK-BASED COMPENSATION
Stock-based Compensation FOLD - Amicus Therapeutics, Inc.
84.9 M
LAST VALUE
5.34%
2 YEAR CAGR
13.83%
5 YEAR CAGR
30.32%
10 YEAR CAGR